Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alfred E Buxton, M.D.

Title
Institution
Department
Address
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01HL045700 (BUXTON, ALFRED E) Sep 30, 1991 - Feb 29, 2000
    NIH/NHLBI
    NONSUSTAINED VENTRICULAR TACHYCARDIA
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Shapira-Daniels A, Barkagan M, Rottmann M, Sroubek J, Tugal D, Carlozzi MA, McConville JW, Buxton AE, Anter E. Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate. Circ Arrhythm Electrophysiol. 2019 06; 12(6):e007336. PMID: 31113232.
    Citations:    
  2. Kramer DB, Buxton AE, Zimetbaum PJ. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt. JAMA Cardiol. 2019 Apr 17. PMID: 30994859.
    Citations:    
  3. Barkagan M, Rottmann M, Leshem E, Shen C, Buxton AE, Anter E. Effect of Baseline Impedance on Ablation Lesion Dimensions. Circ Arrhythm Electrophysiol. 2018 Oct; 11(10):e006690. PMID: 30354405.
    Citations:    Fields:    
  4. Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018 Sep 27; 379(13):1205-1215. PMID: 30280654.
    Citations: 2     Fields:    Translation:Humans
  5. Huikuri H, Buxton AE. Identification of suitable patients for ICD therapy. Int J Cardiol. 2018 12 01; 272:217-218. PMID: 30131232.
    Citations:    Fields:    Translation:Humans
  6. Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M. Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement. Circ Arrhythm Electrophysiol. 2018 Aug; 11(8):e006155. PMID: 30354311.
    Citations:    Fields:    
  7. Anter E, Duytschaever M, Shen C, Strisciuglio T, Leshem E, Contreras-Valdes FM, Waks JW, Zimetbaum PJ, Kumar K, Spector PS, Lee A, Gerstenfeld EP, Nakar E, Bar-Tal M, Buxton AE. Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018 Aug; 11(8):e006536. PMID: 30354312.
    Citations:    Fields:    
  8. Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA. 2018 07 03; 320(1):63-71. PMID: 29971398.
    Citations:    Fields:    Translation:HumansPHPublic Health
  9. Anter E, Kleber AG, Rottmann M, Leshem E, Barkagan M, Tschabrunn CM, Contreras-Valdes FM, Buxton AE. Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm. JACC Clin Electrophysiol. 2018 Aug; 4(8):1033-1048. PMID: 30139485.
    Citations:    
  10. Barkagan M, Contreras-Valdes FM, Leshem E, Buxton AE, Nakagawa H, Anter E. High-power and short-duration ablation for pulmonary vein isolation: Safety, efficacy, and long-term durability. J Cardiovasc Electrophysiol. 2018 Sep; 29(9):1287-1296. PMID: 29846987.
    Citations:    Fields:    
  11. Malik M, Buxton AE, Huikuri H, Lombardi F, Schmidt G, Zabel M. Noninvasive electrophysiology in risk assessment and screening. Heart Rhythm. 2018 06; 15(6):803-804. PMID: 29857851.
    Citations:    Fields:    
  12. Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes. Eur J Heart Fail. 2018 06; 20(6):1031-1038. PMID: 29761861.
    Citations:    Fields:    
  13. Tereshchenko LG, Sotoodehnia N, Sitlani CM, Ashar FN, Kabir M, Biggs ML, Morley MP, Waks JW, Soliman EZ, Buxton AE, Biering-Sørensen T, Solomon SD, Post WS, Cappola TP, Siscovick DS, Arking DE. Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study). J Am Heart Assoc. 2018 Apr 05; 7(8). PMID: 29622589.
    Citations:    Fields:    
  14. Biering-Sørensen T, Kabir M, Waks JW, Thomas J, Post WS, Soliman EZ, Buxton AE, Shah AM, Solomon SD, Tereshchenko LG. Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005961. PMID: 29496680.
    Citations:    Fields:    
  15. Waks JW, Buxton AE. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction. Annu Rev Med. 2018 01 29; 69:147-164. PMID: 29414264.
    Citations:    Fields:    
  16. Adabag S, Patton KK, Buxton AE. Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply. JAMA Cardiol. 2017 12 01; 2(12):1397-1398. PMID: 28973098.
    Citations:    Fields:    
  17. Anter E, Di Biase L, Contreras-Valdes FM, Gianni C, Mohanty S, Tschabrunn CM, Viles-Gonzalez JF, Leshem E, Buxton AE, Kulbak G, Halaby RN, Zimetbaum PJ, Waks JW, Thomas RJ, Natale A, Josephson ME. Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea. Circ Arrhythm Electrophysiol. 2017 Nov; 10(11). PMID: 29133380.
    Citations: 3     Fields:    Translation:Humans
  18. Sroubek J, Buxton AE. Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned? Card Electrophysiol Clin. 2017 12; 9(4):761-773. PMID: 29173416.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  19. Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol. 2017 Nov; 28(11):1345-1351. PMID: 28744959.
    Citations:    Fields:    Translation:Humans
  20. Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 07 01; 2(7):767-774. PMID: 28724134.
    Citations: 2     Fields:    
  21. Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. Am Heart J. 2017 Sep; 191:21-29. PMID: 28888266.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  22. Shenasa M, Miller JM, Callans DJ, Almendral JM, Marchlinski FE, Buxton AE. Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management: Contribution of Mark E. Josephson, MD, to Clinical Electrophysiology. Circ Arrhythm Electrophysiol. 2017 05; 10(5). PMID: 28487348.
    Citations: 1     Fields:    
  23. Buxton A. "What Would He Do Next?" Arrhythm Electrophysiol Rev. 2017 Apr; 6(1):13. PMID: 28507739.
    Citations:    
  24. Buxton AE. Sudden death in ischemic heart disease - 2017. Int J Cardiol. 2017 Jun 15; 237:64-66. PMID: 28365181.
    Citations: 1     Fields:    Translation:Humans
  25. Katritsis DG, Marine JE, Contreras FM, Fujii A, Latchamsetty R, Siontis KC, Katritsis GD, Zografos T, John RM, Epstein LM, Michaud GF, Anter E, Sepahpour A, Rowland E, Buxton AE, Calkins H, Morady F, Stevenson WG, Josephson ME. Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia. Circulation. 2016 Nov 22; 134(21):1655-1663. PMID: 27754882.
    Citations: 2     Fields:    Translation:Humans
  26. Buxton AE, Waks JW, Shen C, Chen PS. Risk stratification for sudden cardiac death in North America - current perspectives. J Electrocardiol. 2016 Nov - Dec; 49(6):817-823. PMID: 27524476.
    Citations: 1     Fields:    Translation:Humans
  27. Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit. Circulation. 2016 Jul 26; 134(4):314-27. PMID: 27440005.
    Citations: 12     Fields:    Translation:Animals
  28. Shen C, Hu Y, Li X, Wang Y, Chen PS, Buxton AE. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree. Biom J. 2016 Nov; 58(6):1357-1375. PMID: 27356196.
    Citations:    Fields:    Translation:Humans
  29. Waks JW, Sitlani CM, Soliman EZ, Kabir M, Ghafoori E, Biggs ML, Henrikson CA, Sotoodehnia N, Biering-Sørensen T, Agarwal SK, Siscovick DS, Post WS, Solomon SD, Buxton AE, Josephson ME, Tereshchenko LG. Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Circulation. 2016 Jun 07; 133(23):2222-34. PMID: 27081116.
    Citations: 8     Fields:    Translation:Humans
  30. Brooks GC, Lee BK, Rao R, Lin F, Morin DP, Zweibel SL, Buxton AE, Pletcher MJ, Vittinghoff E, Olgin JE. Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study. J Am Coll Cardiol. 2016 Mar 15; 67(10):1186-1196. PMID: 26965540.
    Citations: 8     Fields:    Translation:Humans
  31. Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2016 Mar; 9(3):e003283. PMID: 26921377.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  32. Serber ER, Fava JL, Christon LM, Buxton AE, Goldberger JJ, Gold MR, Rodrigue JR, Frisch MB. Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol. 2016 May; 39(5):458-70. PMID: 26813033.
    Citations: 1     Fields:    Translation:Humans
  33. Levine YC, Matos J, Rosenberg MA, Manning WJ, Josephson ME, Buxton AE. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy. Heart Rhythm. 2016 Feb; 13(2):490-7. PMID: 26409099.
    Citations: 2     Fields:    Translation:Humans
  34. Shvilkin A, Ellis ER, Gervino EV, Litvak AD, Buxton AE, Josephson ME. Painful left bundle branch block syndrome: Clinical and electrocardiographic features and further directions for evaluation and treatment. Heart Rhythm. 2016 Jan; 13(1):226-32. PMID: 26331973.
    Citations: 2     Fields:    Translation:Humans
  35. Huang HD, Waks JW, Contreras-Valdes FM, Haffajee C, Buxton AE, Josephson ME. Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter. Europace. 2016 Apr; 18(4):521-30. PMID: 26311563.
    Citations: 1     Fields:    Translation:Humans
  36. Sciammarella MG, Gerson M, Buxton AE, Bartley SC, Doukky R, Merlino DA, Tandon S, Thompson R, Travin MI. ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine-123 meta-iodobenzylguanidine ((123)I-mIBG). J Nucl Cardiol. 2015 Aug; 22(4):804-11. PMID: 26163203.
    Citations: 4     Fields:    Translation:Humans
  37. Tschabrunn CM, Roujol S, Nezafat R, Faulkner-Jones B, Buxton AE, Josephson ME, Anter E. A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2016 Jan; 13(1):262-73. PMID: 26226214.
    Citations: 12     Fields:    Translation:HumansAnimals
  38. Katritsis DG, Marine JE, Latchamsetty R, Zografos T, Tanawuttiwat T, Sheldon SH, Buxton AE, Calkins H, Morady F, Josephson ME. Coexistent Types of Atrioventricular Nodal Re-Entrant Tachycardia: Implications for the Tachycardia Circuit. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1189-93. PMID: 26155802.
    Citations: 3     Fields:    Translation:Humans
  39. Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46. PMID: 26038525.
    Citations: 7     Fields:    Translation:Humans
  40. Contreras-Valdes FM, Buxton AE, Josephson ME, Anter E. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. J Am Coll Cardiol. 2015 Apr 14; 65(14):1485-7. PMID: 25857916.
    Citations: 3     Fields:    Translation:Humans
  41. Tschabrunn CM, Silverstein J, Berzin T, Ellis E, Buxton AE, Josephson ME, Anter E. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015 Jun; 17(6):891-7. PMID: 25777771.
    Citations: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
  42. Levine YC, Tuttle MK, Rosenberg MA, Goldberg R, Matos J, Samuel M, Kramer DB, Buxton AE. Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. Am J Cardiol. 2015 Jun 01; 115(11):1539-44. PMID: 25840578.
    Citations:    Fields:    Translation:HumansPHPublic Health
  43. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):179-86. PMID: 25669833.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  44. Waks JW, Higgins AY, Mittleman MA, Buxton AE. Influence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement. J Cardiovasc Electrophysiol. 2015 Mar; 26(3):282-90. PMID: 25431143.
    Citations: 1     Fields:    Translation:Humans
  45. Buxton AE, Wilde AA, Chen PS. A new ECG section in HeartRhythm by Josephson and Wellens. Heart Rhythm. 2014 Dec; 11(12):2328. PMID: 25454059.
    Citations:    
  46. Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. JACC Heart Fail. 2014 Dec; 2(6):623-9. PMID: 25306452.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  47. Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, Buxton AE, Josephson ME, Gelfand E, Manning WJ. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014 Nov; 11(11):1890-7. PMID: 25034183.
    Citations: 9     Fields:    Translation:Humans
  48. Levine YC, Rosenberg MA, Mittleman M, Samuel M, Methachittiphan N, Link M, Josephson ME, Buxton AE. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. Heart Rhythm. 2014 Jul; 11(7):1109-16. PMID: 24837348.
    Citations: 7     Fields:    Translation:Humans
  49. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Warner Stevenson L, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303. PMID: 24819194.
    Citations: 2     Fields:    Translation:Humans
  50. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125. PMID: 24815500.
    Citations: 19     Fields:    Translation:Humans
  51. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014 Sep 16; 64(11):1143-77. PMID: 24820349.
    Citations: 13     Fields:    Translation:Humans
  52. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 01; 35(25):1642-51. PMID: 24801071.
    Citations: 47     Fields:    Translation:Humans
  53. Warraich HJ, Buxton AE, Kociol RD. Macroscopic T-wave alternans in a patient with takotsubo cardiomyopathy and QT prolongation. Heart Rhythm. 2014 Oct; 11(10):1848-9. PMID: 24607719.
    Citations: 2     Fields:    Translation:Humans
  54. Anter E, Tschabrunn CM, Contreras-Valdes FM, Buxton AE, Josephson ME. Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. Heart Rhythm. 2014 May; 11(5):783-90. PMID: 24583098.
    Citations: 7     Fields:    Translation:Humans
  55. Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, Buxton AE, Chen PS. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55. PMID: 24566233.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  56. Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014 Jul; 64(1):32-9. PMID: 24518128.
    Citations: 24     Fields:    Translation:HumansPHPublic Health
  57. Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb; 11(2):216-21. PMID: 24513917.
    Citations: 8     Fields:    Translation:Humans
  58. Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM, Chen PS, Chugh SS, Costantini O, Exner DV, Kadish AH, Lee B, Lloyd-Jones D, Moss AJ, Myerburg RJ, Olgin JE, Passman R, Stevenson WG, Tomaselli GF, Zareba W, Zipes DP, Zoloth L. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014 Jan 28; 129(4):516-26. PMID: 24470473.
    Citations: 35     Fields:    Translation:Humans
  59. Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders GD. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? Int J Cardiol. 2014 Mar 01; 172(1):253-4. PMID: 24467982.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  60. Buxton AE. Programmed ventricular stimulation: not dead. Circulation. 2014 Feb 25; 129(8):831-3. PMID: 24381210.
    Citations: 4     Fields:    Translation:Humans
  61. Rosenberg MA, Lopez FL, Bužková P, Adabag S, Chen LY, Sotoodehnia N, Kronmal RA, Siscovick DS, Alonso A, Buxton A, Folsom AR, Mukamal KJ. Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ann Epidemiol. 2014 Mar; 24(3):174-179.e2. PMID: 24360853.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  62. Shen C, Jeong J, Li X, Chen PS, Buxton A. Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect. Biometrics. 2013 Sep; 69(3):724-31. PMID: 23865447.
    Citations:    Fields:    Translation:Humans
  63. Goldberger JJ, Buxton AE. Personalized medicine vs guideline-based medicine. JAMA. 2013 Jun 26; 309(24):2559-60. PMID: 23712449.
    Citations: 18     Fields:    Translation:Humans
  64. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97. PMID: 23759471.
    Citations: 15     Fields:    Translation:Humans
  65. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23; 62(4):300-5. PMID: 23623910.
    Citations: 52     Fields:    Translation:Humans
  66. Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, Shaw JL, Hong SN, Zimetbaum P, Buxton AE, Josephson ME, Manning WJ, Nezafat R. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy. J Cardiovasc Magn Reson. 2013 Apr 10; 15:31. PMID: 23574733.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  67. Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm. 2013 Jun; 10(6):828-35. PMID: 23416381.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  68. Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R. Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation. Am J Cardiol. 2013 Apr 15; 111(8):1175-9. PMID: 23375599.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  69. Buxton AE. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. J Am Coll Cardiol. 2012 Oct 23; 60(17):1656-8. PMID: 23021332.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  70. Anter E, Buxton AE, Silverstein JR, Josephson ME. Idiopathic ventricular fibrillation originating from the moderator band. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):97-100. PMID: 22882745.
    Citations: 5     Fields:    Translation:Humans
  71. Tan AY, Abdi S, Buxton AE, Anter E. Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. Heart Rhythm. 2012 Dec; 9(12):2063-7. PMID: 22863887.
    Citations: 5     Fields:    Translation:Humans
  72. Cheng A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R. Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing Clin Electrophysiol. 2012 Aug; 35(8):912-8. PMID: 22670627.
    Citations: 2     Fields:    Translation:Humans
  73. Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change--a new approach to ICD replacement. N Engl J Med. 2012 Jan 26; 366(4):291-3. PMID: 22276818.
    Citations: 16     Fields:    Translation:Humans
  74. Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med. 2012 Jan 09; 172(1):64-7. PMID: 22082711.
    Citations: 5     Fields:    Translation:Humans
  75. Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2011 Sep 27; 58(14):1517-38. PMID: 21880456.
    Citations: 2     Fields:    Translation:Humans
  76. Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Circulation. 2011 Sep 27; 124(13):1483-502. PMID: 21875906.
    Citations: 2     Fields:    Translation:Humans
  77. Wadehra V, Buxton AE, Antoniadis AP, McCready JW, Redpath CJ, Segal OR, Rowland E, Lowe MD, Lambiase PD, Chow AW. The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace. 2011 Oct; 13(10):1401-5. PMID: 21828065.
    Citations: 7     Fields:    Translation:Humans
  78. Weintraub WS, Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, Fonarow GC, Goldberg LR, Heidenreich P, Hendel RC, Jacobs AK, Lewis W, Mirro MJ, Shahian DM. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2011 Jul 05; 58(2):202-22. PMID: 21652161.
    Citations: 16     Fields:    Translation:Humans
  79. Weintraub WS, Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, Fonarow GC, Goldberg LR, Heidenreich P, Hendel RC, Jacobs AK, Lewis W, Mirro MJ, Shahian DM, Hendel RC, Bozkurt B, Jacobs JP, Peterson PN, Roger VL, Smith EE, Tcheng JE, Wang T. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Circulation. 2011 Jul 05; 124(1):103-23. PMID: 21646493.
    Citations: 8     Fields:    Translation:Humans
  80. Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP, Lloyd-Jones D, Kadish AH, Lee B, Moss A, Myerburg R, Olgin J, Passman R, Rosenbaum D, Stevenson W, Zareba W, Zipes DP. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011 May 31; 123(21):2423-30. PMID: 21632516.
    Citations: 30     Fields:    Translation:Humans
  81. Buxton AE. Sudden cardiac death won't go away: what are we to do? Heart Rhythm. 2011 Aug; 8(8):1183-4. PMID: 21699829.
    Citations: 2     Fields:    Translation:Humans
  82. Lorvidhaya P, Addo K, Chodosh A, Iyer V, Lum J, Buxton AE. Sudden cardiac death risk stratification in patients with heart failure. Heart Fail Clin. 2011 Apr; 7(2):157-74, vii. PMID: 21439495.
    Citations: 6     Fields:    Translation:Humans
  83. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen PS, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O'Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng ZJ. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010 Nov 30; 122(22):2335-48. PMID: 21147730.
    Citations: 126     Fields:    Translation:Humans
  84. AlMahameed ST, Buxton AE, Michaud GF. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):578-84. PMID: 20971759.
    Citations: 2     Fields:    Translation:Humans
  85. Buxton AE. Implantable loop recorder in survivors of acute myocardial infarction: a glimpse of reality? Circulation. 2010 Sep 28; 122(13):1255-7. PMID: 20837889.
    Citations: 1     Fields:    Translation:Humans
  86. Mellion ML, Buxton AE, Iyer V, Almahameed S, Lorvidhaya P, Gilchrist JM. Safety of nerve conduction studies in patients with peripheral intravenous lines. Muscle Nerve. 2010 Aug; 42(2):189-91. PMID: 20658600.
    Citations: 2     Fields:    Translation:Humans
  87. Al-Khatib SM, Hafley G, Lee KL, Buxton AE. Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace. 2010 Aug; 12(8):1112-8. PMID: 20452992.
    Citations: 2     Fields:    Translation:Humans
  88. Buxton AE, Ellison KE, Lorvidhaya P, Ziv O. Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation. J Cardiovasc Pharmacol. 2010 May; 55(5):450-5. PMID: 20509178.
    Citations: 4     Fields:    Translation:Humans
  89. Piccini JP, Al-Khatib SM, Myers ER, Anstrom KJ, Buxton AE, Peterson ED, Sanders GD. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis. J Cardiovasc Electrophysiol. 2010 Jul; 21(7):791-8. PMID: 20132397.
    Citations: 3     Fields:    Translation:Humans
  90. Ziv O, Morales E, Song YK, Peng X, Odening KE, Buxton AE, Karma A, Koren G, Choi BR. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome. J Physiol. 2009 Oct 01; 587(Pt 19):4661-80. PMID: 19675070.
    Citations: 18     Fields:    Translation:Animals
  91. Piccini JP, Hafley GE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Buxton AE. Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT). J Cardiovasc Electrophysiol. 2009 Aug; 20(8):850-5. PMID: 19490266.
    Citations: 4     Fields:    Translation:Humans
  92. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK, Biehl M, Tomassoni G, Leonen A, Klevan LR, Hallstrom AP. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol. 2009 Mar 10; 53(10):872-80. PMID: 19264245.
    Citations: 9     Fields:    Translation:Humans
  93. Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm. 2009 Jun; 6(6):836-47. PMID: 19467514.
    Citations: 14     Fields:    Translation:Humans
  94. Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, Knuuti J, Flotats A, Arrighi J, Muxi A, Alibelli MJ, Banerjee G, Jacobson AF. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008 Sep; 1(2):131-40. PMID: 19808530.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  95. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008 Jun 19; 358(25):2667-77. PMID: 18565859.
    Citations: 218     Fields:    Translation:Humans
  96. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007 Sep 18; 50(12):1150-7. PMID: 17868806.
    Citations: 83     Fields:    Translation:Humans
  97. Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, Josephson ME, Zimetbaum P. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27; 167(15):1648-53. PMID: 17698688.
    Citations: 3     Fields:    Translation:Humans
  98. Stanchina ML, Ellison K, Malhotra A, Anderson M, Kirk M, Benser ME, Tosi C, Carlisle C, Millman RP, Buxton A. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest. 2007 Aug; 132(2):433-9. PMID: 17573498.
    Citations: 25     Fields:    Translation:Humans
  99. Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J. 2007 Jun; 153(6):941-50. PMID: 17540194.
    Citations: 6     Fields:    Translation:Humans
  100. Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J. 2007 Jun; 153(6):951-9. PMID: 17540195.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  101. Fisher JD, Buxton AE, Lee KL, Packer DL, Echt DS, Denes P, Lehmann MH, DiMarco JP, Roy D, Hafley GE. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). Am J Cardiol. 2007 Jul 01; 100(1):76-83. PMID: 17599445.
    Citations: 6     Fields:    Translation:Humans
  102. Ott P, Kirk MM, Koo C, He DS, Bhattacharya B, Buxton A. Coronary sinus and fossa ovalis ablation: effect on interatrial conduction and atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Mar; 18(3):310-7. PMID: 17257123.
    Citations: 2     Fields:    Translation:Animals
  103. Frain BH, Ellison KE, Michaud GF, Koo CH, Buxton AE, Kirk MM. True bipolar defibrillator leads have increased sensing latency and threshold compared with the integrated bipolar configuration. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):192-5. PMID: 17239139.
    Citations: 1     Fields:    Translation:Humans
  104. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Heidenreich PA, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). J Am Coll Cardiol. 2006 Dec 05; 48(11):2360-96. PMID: 17161282.
    Citations: 10     Fields:    Translation:Humans
  105. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. Rev Esp Cardiol. 2006 Dec; 59(12):1328. PMID: 17194428.
    Citations: 7     Fields:    Translation:Humans
  106. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation. 2006 Dec 05; 114(23):2534-70. PMID: 17130345.
    Citations: 27     Fields:    Translation:Humans
  107. Buxton AE. Implantable cardioverter-defibrillators should be used routinely in the elderly. Am J Geriatr Cardiol. 2006 Nov-Dec; 15(6):361-4; quiz 365-6. PMID: 17086029.
    Citations: 3     Fields:    Translation:Humans
  108. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006 Sep 05; 48(5):e247-346. PMID: 16949478.
    Citations: 198     Fields:    Translation:Humans
  109. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140. PMID: 16923744.
    Citations: 66     Fields:    Translation:Humans
  110. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):746-837. PMID: 16935866.
    Citations: 81     Fields:    Translation:Humans
  111. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 05; 114(10):e385-484. PMID: 16935995.
    Citations: 222     Fields:    Translation:Humans
  112. Buxton AE. Identifying the high risk patient with coronary artery disease--is ejection fraction all you need? J Cardiovasc Electrophysiol. 2005 Sep; 16 Suppl 1:S25-7. PMID: 16138881.
    Citations: 4     Fields:    Translation:Humans
  113. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol. 2005 Jul 19; 46(2):310-6. PMID: 16022960.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  114. Buxton AE. Sudden death after myocardial infarction--who needs prophylaxis, and when? N Engl J Med. 2005 Jun 23; 352(25):2638-40. PMID: 15972871.
    Citations: 4     Fields:    Translation:Humans
  115. Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J. 2005 Jun; 149(6):1020-34. PMID: 15976783.
    Citations: 14     Fields:    Translation:Humans
  116. Buxton AE. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation. 2005 May 17; 111(19):2537-49; discussion 2537-49. PMID: 15897357.
    Citations: 12     Fields:    Translation:Humans
  117. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol. 2004 Sep; 15(9):993-8. PMID: 15363069.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  118. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004 Aug 17; 110(7):766-9. PMID: 15289365.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  119. Buxton AE. Direct current cardioversion for atrial fibrillation and flutter. Med Health R I. 2004 Apr; 87(4):97. PMID: 15168632.
    Citations:    Fields:    Translation:Humans
  120. Buxton A. Acute management of atrial fibrillation. Med Health R I. 2004 Apr; 87(4):94-6. PMID: 15168631.
    Citations:    Fields:    Translation:Humans
  121. Buxton AE. Atrial fibrillation and flutter: overview. Med Health R I. 2004 Apr; 87(4):92-3. PMID: 15168630.
    Citations:    Fields:    Translation:Humans
  122. Buxton AE. Risk stratification for sudden death: do we need anything more than ejection fraction? Card Electrophysiol Rev. 2003 Dec; 7(4):434-7. PMID: 15071270.
    Citations: 5     Fields:    Translation:Humans
  123. Buxton AE, Ellison KE, Kirk MM, Frain B, Koo C, Gandhi G, Khouzam S. Primary prevention of sudden cardiac death: trials in patients with coronary artery disease. J Interv Card Electrophysiol. 2003 Oct; 9(2):203-6. PMID: 14574032.
    Citations:    Fields:    Translation:HumansPHPublic Health
  124. Russo AM, Hafley GE, Lee KL, Stamato NJ, Lehmann MH, Page RL, Kus T, Buxton AE. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation. 2003 Jul 08; 108(1):67-72. PMID: 12821551.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  125. Buxton AE. The clinical use of implantable cardioverter defibrillators: where are we now? Where should we go? Ann Intern Med. 2003 Mar 18; 138(6):512-4. PMID: 12639087.
    Citations: 2     Fields:    Translation:Humans
  126. Nicholson WJ, Buxton AE, Tammaro D. Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. Clin Infect Dis. 2003 Feb 01; 36(3):e35-9. PMID: 12539087.
    Citations: 2     Fields:    Translation:Humans
  127. Buxton AE, Kirk MM, Michaud GF, Ellison KE, Nyren L. Management of the non-inducible patient. Card Electrophysiol Rev. 2002 Dec; 6(4):466-71. PMID: 12438830.
    Citations:    Fields:    Translation:Humans
  128. Ellison KE, Hafley GE, Hickey K, Kellen J, Coromilas J, Stein KM, Lee KL, Buxton AE. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). Circulation. 2002 Nov 19; 106(21):2694-9. PMID: 12438295.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  129. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, Gold MR, Packer DL, Josephson ME, Prystowsky EN, Talajic MR. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation. 2002 Nov 05; 106(19):2466-72. PMID: 12417544.
    Citations: 29     Fields:    Translation:Humans
  130. Pires LA, Hafley GE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Buxton AE. Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction. J Cardiovasc Electrophysiol. 2002 Aug; 13(8):757-63. PMID: 12212692.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials